Literature DB >> 23086458

Partial activation of α7 nicotinic acetylcholine receptors: insights from molecular dynamics simulations.

Caijuan Shi1, Rilei Yu, Shengjuan Shao, Yanni Li.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) are drug targets for neuronal disorders and diseases. Partial agonists for nAChRs are currently being developed as drugs for the treatment of neurological diseases for their relative safety originated from reduced excessive stimulation. In the current study, molecular docking, molecular dynamics simulations and binding energy calculations were performed to theoretically investigate the interactions between the partial agonists, 4-OH-DMXBA and tropisetron with α7-nAChR. The results suggest that the partial agonists 4-OH-DMXBA and tropisetron bind with α7-nAChR in a binding mode similar to that with AChBP. The non-conserved residues in the binding sites contribute to the orientation deviation of these partial agonists from their orientation in AChBP. Energy calculation and decomposition using MM-GB/SA suggests that the van der Waals term (ΔE(VDW)) is the main driving force for the binding of the partial agonists to α7-nAChR. The molecular dynamics simulations showed that the opening of the C-loop binding with the partial agonists is in-between the openings for the binding with the full agonist and in the apo state. This conformation difference for the C-loop sheds light on the partial agonism of nAChR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23086458     DOI: 10.1007/s00894-012-1618-6

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  23 in total

1.  The 5-HT3 antagonist tropisetron (ICS 205-930) is a potent and selective alpha7 nicotinic receptor partial agonist.

Authors:  J E Macor; D Gurley; T Lanthorn; J Loch; R A Mack; G Mullen; O Tran; N Wright; J C Gordon
Journal:  Bioorg Med Chem Lett       Date:  2001-02-12       Impact factor: 2.823

Review 2.  Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations.

Authors:  Anders A Jensen; Bente Frølund; Tommy Liljefors; Povl Krogsgaard-Larsen
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

3.  Heterogeneity of nicotinic cholinergic receptors in rat superior cervical and nodose Ganglia.

Authors:  Danyan Mao; Robert P Yasuda; Hong Fan; Barry B Wolfe; Kenneth J Kellar
Journal:  Mol Pharmacol       Date:  2006-08-01       Impact factor: 4.436

Review 4.  Recent advances in understanding the structure of nicotinic acetylcholine receptors.

Authors:  Marios Zouridakis; Paraskevi Zisimopoulou; Konstantinos Poulas; Socrates J Tzartos
Journal:  IUBMB Life       Date:  2009-04       Impact factor: 3.885

Review 5.  Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.

Authors:  H Rheinallt Parri; Caterina M Hernandez; Kelly T Dineley
Journal:  Biochem Pharmacol       Date:  2011-07-07       Impact factor: 5.858

6.  Crystal structures of a cysteine-modified mutant in loop D of acetylcholine-binding protein.

Authors:  Marijke Brams; Elaine A Gay; José Colón Sáez; Albert Guskov; René van Elk; Roel C van der Schors; Steve Peigneur; Jan Tytgat; Sergei V Strelkov; August B Smit; Jerrel L Yakel; Chris Ulens
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

7.  Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist.

Authors:  Roger L Papke; Hillary C Schiff; Brian A Jack; Nicole A Horenstein
Journal:  Neurosci Lett       Date:  2005-01-05       Impact factor: 3.046

8.  Spectroscopic analysis of benzylidene anabaseine complexes with acetylcholine binding proteins as models for ligand-nicotinic receptor interactions.

Authors:  Todd T Talley; Samar Yalda; Kwok-Yiu Ho; Yitzhak Tor; Ferene S Soti; William R Kem; Palmer Taylor
Journal:  Biochemistry       Date:  2006-07-25       Impact factor: 3.162

9.  Loss of nicotinic acetylcholine receptor subunits alpha4 and alpha7 in the cerebral cortex of Parkinson patients.

Authors:  Lothar Burghaus; Ulrich Schütz; Udo Krempel; Jon Lindstrom; Hannsjörg Schröder
Journal:  Parkinsonism Relat Disord       Date:  2003-06       Impact factor: 4.891

10.  Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.

Authors:  Roger L Papke; Julia K Porter Papke
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

View more
  4 in total

1.  Therapeutic action of 5-HT3 receptor antagonists targeting peritoneal macrophages in post-operative ileus.

Authors:  Toko Maehara; Kenjiro Matsumoto; Kazuhide Horiguchi; Makoto Kondo; Satoshi Iino; Shunji Horie; Takahisa Murata; Hirokazu Tsubone; Shoichi Shimada; Hiroshi Ozaki; Masatoshi Hori
Journal:  Br J Pharmacol       Date:  2015-01-13       Impact factor: 8.739

2.  Dual-inhibitors of STAT5 and STAT3: studies from molecular docking and molecular dynamics simulations.

Authors:  Shengjuan Shao; Rilei Yu; Yanqing Yu; Yanni Li
Journal:  J Mol Model       Date:  2014-08-07       Impact factor: 1.810

Review 3.  Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson's disease.

Authors:  George E Barreto; Alexander Iarkov; Valentina Echeverria Moran
Journal:  Front Aging Neurosci       Date:  2015-01-09       Impact factor: 5.750

4.  Conformational changes in acetylcholine binding protein investigated by temperature accelerated molecular dynamics.

Authors:  Zeynab Mohammad Hosseini Naveh; Therese E Malliavin; Luca Maragliano; Grazia Cottone; Giovanni Ciccotti
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.